Gov. Dayton denies suggesting mother buy pot on the street
March 28, 2014 — 4:37pm
Gov. Mark Dayton said Friday that there isn’t enough research to back medical marijuana in Minnesota, and denied allegations by the mother of a sick child that he suggested she buy marijuana on the street.
Asked to elaborate on why the claim was made, Dayton said simply. “I don’t know.”
“I’ve said all I’m going to say about medical marijuana, I’ve issued a statement, I’ve answered questions, I’m just not going to discuss it further.”
Dayton backed his stance opposing medical marijuana on the grounds that it’s an unresearched medical issue, adding that his opinions are influenced in part by the Minnesota Medical Association, Minnesota Psychiatric Association and his own Commissioner of Health. He said in the past, unresearched prescription drugs have had “horrific” impacts.
“There’s protocol that proponents of legalizing this want to ignore. I don’t think that’s wise; I don’t think that’s in the best inteersts of most of Minnesotans.” He said. “I greatly sympathize with their plight, to have a child or any loved one who’s suffering like they are and the anguish is terrible to witness, but we’re making policy here and passing laws for 5.3 million people, but on the medical side this is the best judgment for most Minnesotans.”
Dayton said dealing with the backlash hasn't been easy.
"It's very hard to be vilified; it's very hard to be told that I don't care about sick people and their suffering. I'm in this to help people." he said.
Gov. Mark Dayton, speaking to a mostly Republican audience at the annual Minnesota Business Partnership dinner, repeated his familiar attack on the House GOP, blaming them for a legislative impasse on transportation.
Just hours after his first presidential debate with Hillary Clinton, Donald Trump lashed out at the debate moderator, complained about his microphone and threatened to make Bill Clinton's marital infidelity a campaign issue.
Wells Fargo says CEO John Stumpf and the executive who ran the bank's retail banking division will forfeit tens of millions of dollars in pay as the bank tries to stem a scandal over its sales practices.
The compromise would require patients to certify they are qualified to receive cannabis to get the drug from one of eight distribution centers. Only two manufacturing sites would be permitted under the deal.